Replies to post #367526 on Amarin Corp Plc (AMRN)

[Whalatane]

Actually it’s profits that matter and how capital is used to generate those profits … thus the entrance of Denner on the scene
Kiwi

[Number sleven]

Bouf, Sales of Vascepa in the US market have been impacted by the presence of generic products. This is not because the generic product is taking the market. It's all about the effects of generic presence on formularies. If marjac wins in court, the generic product would be removed from the formularies. The result would be an immediate increase in sales.
Sleven,

[Meowza]

attenuated

On that note, Brandumb's tail tucked hard regarding forced pokes. He'll force anyone to do anything. Anything except DPA on behalf of producing a conventional vax platform, he won't make anyone do that.

[L0tsaluck2000]

A legal victory doesn't produce sales but it does shift gV sales to V AND it restores the logic and value of advertising and promotion that will grow sales. We never got our hockey stick of growing sales. COVID, lack of marketing and feeble efforts when they were doing limited marketing and push back by the likes of Nissen resulted in V never growing like we and most professionals predicted.

Also, we have learned that cost sensitivity and 4 big pills seem to create a patient retention problem that hadn't been anticipated by some.